Daniela Westerwick
Overview
Explore the profile of Daniela Westerwick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwertheim S, Theurer S, Jastrow H, Herold T, Ting S, Westerwick D, et al.
PLoS One
. 2019 Dec;
14(12):e0226199.
PMID: 31841566
Background: Intranuclear inclusions (NI) in normal and neoplastic tissues have been known for years, representing one of the diagnostic criteria for papillary thyroid carcinoma (PTC). BRAF activation is involved among...
2.
Buderath P, Mairinger F, Mairinger E, Bohm K, Mach P, Schmid K, et al.
Int J Gynecol Cancer
. 2019 Sep;
29(9):1389-1395.
PMID: 31492714
Introduction: Ovarian carcinoma is associated with the highest mortality of all gynecologic malignancies. Even after optimal treatment, prognosis remains poor. There is no established biomarker to predict individual patient outcome....
3.
Schwertheim S, Westerwick D, Jastrow H, Theurer S, Schaefer C, Kalsch J, et al.
J Pathol Clin Res
. 2019 Mar;
5(3):164-176.
PMID: 30859721
For decades, intranuclear inclusions in many normal and neoplastic cells have been considered to be mere invaginations of cytoplasm into the nucleus without any notable function or influence on disease....
4.
Reis H, Metzenmacher M, Goetz M, Savvidou N, Darwiche K, Aigner C, et al.
Clin Lung Cancer
. 2018 Apr;
19(4):e441-e463.
PMID: 29631966
Background: The receptor tyrosine kinase MET is implicated in malignant transformation, tumor progression, metastasis, and acquired treatment resistance. We conducted an analysis of the effect of MET expression and MET...
5.
Breitenbuecher F, von Pawel J, Sebastian M, Kortsik C, Ting S, Kasper S, et al.
Oncol Res Treat
. 2017 Jun;
40(7-8):435-439.
PMID: 28628916
Background: Polo like kinase 1 (PLK1) is frequently upregulated in tumors and is thus viewed as a promising therapeutic target in various cancers. Several PLK1 inhibitors have recently been developed...
6.
Kalsch J, Padden J, Bertram S, Pott L, Reis H, Westerwick D, et al.
Virchows Arch
. 2017 Mar;
470(5):537-543.
PMID: 28357490
Discriminating intrahepatic cholangiocarcinoma (ICC) from hepatic metastases of pancreatic ductal adenocarcinoma (mPDAC) can be challenging. While pathologists might depend on clinical information regarding a primary tumor, their diagnosis will lead...
7.
Pesch B, Casjens S, Stricker I, Westerwick D, Taeger D, Rabstein S, et al.
PLoS One
. 2012 Oct;
7(9):e45305.
PMID: 23028920
Background: Radon and arsenic are established pulmonary carcinogens. We investigated the association of cumulative exposure to these carcinogens with NOTCH1, HIF1A and other cancer-specific proteins in lung tissue from uranium...